StonvexLoading…
StonvexStonvexStonvexCore line items from CREX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $57.23M | $50.85M | $45.17M | $43.35M |
Operating Income | $-8.87M | $938.00K | $1.35M | $-2.48M |
Net Income | $-8.28M | $-3.51M | $-2.94M | $1.88M |
EPS (Diluted) | $-0.81 | $-0.34 | $-0.35 | $0.28 |
Total Assets | $151.04M | $65.21M | $70.78M | $66.02M |
Total Liabilities | $101.85M | $39.75M | $41.95M | $40.44M |
Cash & Equivalents | $1.56M | $1.04M | $2.91M | $1.63M |
Free Cash Flow OCF − CapEx | $-8.06M | $3.37M | $4.86M | $-857.00K |
Shares Outstanding | 10.52M | 10.45M | 10.41M | 7.27M |